Twist Bioscience (MIL:1TWST) Retained Earnings: €-1,240.5 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MIL:1TWST Twist Bioscience Corp MIL:1TWST
47 GF Score
Price €97.44
GF Value €46.60
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is Twist Bioscience Retained Earnings?

Twist Bioscience MIL:1TWST +0.64% 47 Retained Earnings is €-1,240.5 Mil as of Jun. 2026. GuruFocus rates MIL:1TWST with a GF Score™ of 47/100 and a GF Value™ of €46.60 (Significantly Overvalued). The stock has 5 warning signs investors should review.

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. Twist Bioscience's retained earnings for the quarter that ended in Jun. 2026 was €-1,240.5 Mil.

Twist Bioscience's quarterly retained earnings declined from Dec. 2025 (€-1,153.0 Mil) to Mar. 2026 (€-1,205.9 Mil) and declined from Mar. 2026 (€-1,205.9 Mil) to Jun. 2026 (€-1,240.5 Mil).

Twist Bioscience's annual retained earnings declined from Sep. 2023 (€-968.0 Mil) to Sep. 2024 (€-1,119.0 Mil) and declined from Sep. 2024 (€-1,119.0 Mil) to Sep. 2025 (€-1,124.3 Mil).


Twist Bioscience  (MIL:1TWST) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.


Twist Bioscience Retained Earnings Historical Data

* Premium members only.

The historical data trend for Twist Bioscience's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Twist Bioscience Retained Earnings Chart

Twist Bioscience Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Retained Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only -518.97 -836.70 -967.95 -1,118.96 -1,124.28

Twist Bioscience Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Retained Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1,120.55 -1,124.28 -1,152.97 -1,205.90 -1,240.51
MIL:1TWST
47GF Score
Twist Bioscience Corp MIL:1TWST
Retained Earnings is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Twist Bioscience Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.

Frequently Asked Questions Learn more about Retained Earnings →
What does a Retained Earnings of €-1,240.5 Mil mean?
Twist Bioscience (MIL:1TWST) has a Retained Earnings of €-1,240.5 Mil as of Jun. 2026. Retained earnings is the amount of net income not issued to shareholders. View historical data on Twist Bioscience and its competitors.
Is Twist Bioscience's Retained Earnings too high?
Twist Bioscience's current Retained Earnings is €-1,240.5 Mil. Overall, Twist Bioscience has a GF Score™ of 47/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Twist Bioscience's Retained Earnings compare to BLLN and SHC?
Twist Bioscience's Retained Earnings of €-1,240.5 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Retained Earnings for a Medical Diagnostics & Research company?
A good Retained Earnings depends on the Medical Diagnostics & Research industry context. However, Retained Earnings should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Retained Earnings mean?
A high Retained Earnings can signal that a stock is expensive relative to its fundamentals. Retained earnings is the amount of net income not issued to shareholders. View historical data on Twist Bioscience and its competitors. Twist Bioscience's current Retained Earnings is €-1,240.5 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Twist Bioscience stock overvalued right now?
Based on GuruFocus' analysis, Twist Bioscience (MIL:1TWST) is currently considered Significantly Overvalued. The stock's GF Value™ is €46.60, compared to a current price of €97.44 — trading 109.1% above its estimated fair value. The current Retained Earnings is €-1,240.5 Mil. Twist Bioscience's overall GF Score™ is 47/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Retained Earnings calculated?
Retained Earnings is calculated from a company's financial statements. For Twist Bioscience (MIL:1TWST), the current Retained Earnings is €-1,240.5 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Twist Bioscience (MIL:1TWST) Overvalued in 2026?

Based on GuruFocus' analysis, Twist Bioscience stock appears to be overvalued. The current stock price of €97.44 is trading 109.1% above its estimated GF Value™ of €46.60. GuruFocus considers Twist Bioscience to be Significantly Overvalued.

Key valuation signals for MIL:1TWST:

  • Retained Earnings: €-1,240.5 Mil
  • GF Value™: €46.60 vs. price of €97.44 (109.1% above fair value)
  • GF Score™: 47/100 with 5 warning signs

No single metric tells the full story. See the MIL:1TWST stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Twist Bioscience Business Description

Other Exchanges TWST:USA0ME:Germany
Address 681 Gateway Boulevard, South San Francisco, CA, USA, 94080
Twist Bioscience Corp is a synthetic biology company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's proprietary semiconductor-based manufacturing process synthesizes DNA on silicon rather than traditional plastic plates, enabling the production of high-quality synthetic DNA faster, more affordably, and at scale. This platform overcomes conventional inefficiencies, supports cost-effective, high-throughput synthesis, and allows researchers to accelerate innovation. Geographically, the company operates across the Americas, EMEA, and APAC, deriving the majority of its revenue from the Americas.
47GF Score

Get the complete analysis for MIL:1TWST

Retained Earnings is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€97.44
Price
€46.60
GF Value